Caricamento...
Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification
Despite recent refinements to the 21-gene g score, allowing a better identification of patients who may derive no benefit from the addition of adjuvant chemotherapy to that of endocrine therapy, patients with early breast cancer still stand to be over-treated in the setting of clinical and/or genomi...
Salvato in:
| Pubblicato in: | NPJ Breast Cancer |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group UK
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6715716/ https://ncbi.nlm.nih.gov/pubmed/31482106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-019-0123-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|